Brown, Sean P. and Goodwin, Nicole C. and MacMillan, David W. C. (2003) The First Enantioselective Organocatalytic Mukaiyama−Michael Reaction: A Direct Method for the Synthesis of Enantioenriched γ-Butenolide Architecture. Journal of the American Chemical Society, 125 (5). pp. 1192-1194. ISSN 0002-7863. doi:10.1021/ja029095q. https://resolver.caltech.edu/CaltechAUTHORS:20170417-065654426
![[img]](https://authors.library.caltech.edu/style/images/fileicons/application_pdf.png) |
PDF
- Supplemental Material
See Usage Policy. 294kB |
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20170417-065654426
Abstract
The first enantioselective organocatalytic Mukaiyama−Michael reaction using α,β-unsaturated aldehydes has been accomplished. The use of iminium catalysis has provided a new strategy for the enantioselective addition of 2-silyloxy furans to unsaturated aldehydes to generate a variety of butenolide systems, an important chiral synthon found among many natural isolates. The (2S,5S)-5-benzyl-2-tert-butyl-imidazolidinone amine catalyst has been found to mediate the conjugate addition of a wide variety of substituted and unsubstituted silyloxy furans to unsaturated aldehydes. A diverse range of aldehyde substrates can be accommodated in this new organocatalytic transformation. Application of this new asymmetric technology to the enantioselective total synthesis of spiculisporic acid and the corresponding 5-epi-spiculisporic acid analogue is also discussed.
| Item Type: | Article | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related URLs: |
| ||||||||||||||||||||||||||||||||
| Additional Information: | © 2003 American Chemical Society. Received 25 October 2002. Published online 10 January 2003. Published in print 1 February 2003. Financial support was provided by the NIHGMS (R01 GM66142-01) and kind gifts from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Dupont, GlaxoSmithKline, Johnson and Johnson, Lilly, Materia, Merck Research Laboratories, Pfizer, Pharmacia, and Roche Biosciences. We also thank Great Lakes for their generous donation of (S)-phenylalanine. D.W.C.M is grateful for support from the Sloan Foundation and Research Corporation under the Cottrell Scholarship and Research Innovation programs. | ||||||||||||||||||||||||||||||||
| Funders: |
| ||||||||||||||||||||||||||||||||
| Issue or Number: | 5 | ||||||||||||||||||||||||||||||||
| DOI: | 10.1021/ja029095q | ||||||||||||||||||||||||||||||||
| Record Number: | CaltechAUTHORS:20170417-065654426 | ||||||||||||||||||||||||||||||||
| Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20170417-065654426 | ||||||||||||||||||||||||||||||||
| Official Citation: | The First Enantioselective Organocatalytic Mukaiyama−Michael Reaction: A Direct Method for the Synthesis of Enantioenriched γ-Butenolide Architecture Sean P. Brown, Nicole C. Goodwin, and David W. C. MacMillan Journal of the American Chemical Society 2003 125 (5), 1192-1194 DOI: 10.1021/ja029095q | ||||||||||||||||||||||||||||||||
| Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||||||||||||||||||||||||||||
| ID Code: | 76582 | ||||||||||||||||||||||||||||||||
| Collection: | CaltechAUTHORS | ||||||||||||||||||||||||||||||||
| Deposited By: | Ruth Sustaita | ||||||||||||||||||||||||||||||||
| Deposited On: | 17 Apr 2017 16:31 | ||||||||||||||||||||||||||||||||
| Last Modified: | 15 Nov 2021 17:01 |
Repository Staff Only: item control page
